✦ LIBER ✦

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

✍ Scribed by E. Anaissie; M.W. Schuster; D. Hurd; W. Bensinger; J. Mason; J.M. McCarty; R. Rifkin; R. Maziarz; B. Bolwell; J. Mehta; K. Mangan; B. Skikne; C. Abboud; N. Chao; E. Stadtmauer; H. Fernandez; H. Lazarus; P. Westervelt; Y. Halvorsen; R. Gerwien; V. Annino; W. Hahne

Book ID: 116278514
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.11.068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III randomized double-blind plac

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

✍ Mark M. Schubert; Fernanda P. Eduardo; Katherine A. Guthrie; Jean-Claude Franqui 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 304 KB

Abstract of the 20th International Anniv

Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

✍ M. M. Schubert; F. P. Eduardo; K. A. Guthrie; J. C. Franquin; R. J. Bensadoun; C 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 64 KB